Dynamics-Driven Allostery Underlies Ca2+-Mediated Release of SERCA Inhibition by Phospholamban-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamics-Driven Allostery Underlies Ca2+-Mediated Release of SERCA Inhibition by Phospholamban

Published:2020-11 Issue:9 Volume:119 Page:1917-1926
ISSN:0006-3495
Container-title:Biophysical Journal
language:en
Short-container-title:Biophysical Journal

Author:

Raguimova Olga N.,Aguayo-Ortiz Rodrigo,Robia Seth L.,Espinoza-Fonseca L. Michel

Funder

National Heart, Lung, and Blood Institute

National Institute of General Medical Sciences

Publisher

Elsevier BV

Subject

Biophysics

Reference68 articles.

1. SERCA pump level is a critical determinant of Ca(2+)homeostasis and cardiac contractility;Periasamy;J. Mol. Cell. Cardiol,2001

2. H+ countertransport and electrogenicity of the sarcoplasmic reticulum Ca2+ pump in reconstituted proteoliposomes;Yu;Biophys. J,1993

3. Specificity of ligand binding to transport sites: Ca2+ binding to the Ca2+ transport ATPase and its dependence on H+ and Mg2+;Zafar;Arch. Biochem. Biophys,2008

4. Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+;Cantilina;J. Biol. Chem,1993

5. Sarcolipin protein interaction with sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) is distinct from phospholamban protein, and only sarcolipin can promote uncoupling of the SERCA pump;Sahoo;J. Biol. Chem,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phospholamban inhibits the cardiac calcium pump by interrupting an allosteric activation pathway;Journal of Biological Chemistry;2024-05

2. Mechanisms for cardiac calcium pump activation by its substrate and a synthetic allosteric modulator using fluorescence lifetime imaging;PNAS Nexus;2023-12-21

3. Activation mechanism of the cardiac calcium pump by a small-molecule allosteric modulator;2023-09-10

4. Unveiling the intricacies of intracellular Ca2+ regulation in the heart;Biophysical Journal;2023-08

5. AlphaFold, allosteric, and orthosteric drug discovery: Ways forward;Drug Discovery Today;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3